BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $14.4 million in its second quarter.
On a per-share basis, the Bethesda, Maryland-based company said it had a loss of 1 cent.
The cancer drug developer posted revenue of $201,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source Associated Press News